Literature DB >> 24002517

The just price of cancer drugs and the growing cost of cancer care: oncologists need to be part of the solution.

David G Pfister1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24002517     DOI: 10.1200/JCO.2013.50.3466

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  The project data sphere initiative: accelerating cancer research by sharing data.

Authors:  Angela K Green; Katherine E Reeder-Hayes; Robert W Corty; Ethan Basch; Mathew I Milowsky; Stacie B Dusetzina; Antonia V Bennett; William A Wood
Journal:  Oncologist       Date:  2015-04-15

2.  Attitude of Iranian Medical Oncologists Toward Economic Aspects, and Policy-making in Relation to New Cancer Drugs.

Authors:  Rajabali Daroudi; Mehrzad Mirzania; Kazem Zendehdel
Journal:  Int J Health Policy Manag       Date:  2015-10-20

3.  A catalyst for change: the European cancer Patient's Bill of Rights.

Authors:  Mark Lawler; Thierry Le Chevalier; Martin J Murphy; Ian Banks; Pierfranco Conte; Francesco De Lorenzo; Françoise Meunier; H M Pinedo; Peter Selby; Jean-Pierre Armand; Mariano Barbacid; Michèle Barzach; Jonas Bergh; Gerlind Bode; David A Cameron; Filippo de Braud; Aimery de Gramont; Volker Diehl; Sarper Diler; Sema Erdem; John M Fitzpatrick; Jan Geissler; Donal Hollywood; Liselotte Højgaard; Denis Horgan; Jacek Jassem; Peter W Johnson; Peter Kapitein; Joan Kelly; Sandra Kloezen; Carlo La Vecchia; Bob Löwenberg; Kathy Oliver; Richard Sullivan; Josep Tabernero; Cornelis J Van de Velde; Nils Wilking; Roger Wilson; Christoph Zielinski; Harald Zur Hausen; Patrick G Johnston
Journal:  Oncologist       Date:  2014-02-03

4.  Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists.

Authors:  C Camps-Herrero; L Paz-Ares; M Codes; R López-López; A Antón-Torres; P Gascón-Vilaplana; V Guillem-Porta; A Carrato; J J Cruz-Hernández; C Caballero-Díaz; A Blasco-Cordellat; J A Moreno-Nogueira; E Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2014-06-13       Impact factor: 3.405

5.  PACE Continuous Innovation Indicators-a novel tool to measure progress in cancer treatments.

Authors:  Silvia Paddock; Lauren Brum; Kathleen Sorrow; Samuel Thomas; Susan Spence; Catharina Maulbecker-Armstrong; Clifford Goodman; Michael Peake; Gordon McVie; Gary Geipel; Rose Li
Journal:  Ecancermedicalscience       Date:  2015-01-07

6.  Linking the Price of Cancer Drug Treatments to Their Clinical Value.

Authors:  Lucia Gozzo; Andrea Navarria; Valentina Drago; Laura Longo; Silvana Mansueto; Giacomo Pignataro; Americo Cicchetti; Salvatore Salomone; Filippo Drago
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

Review 7.  Influences of the Results from STRIVE Trial on the Combination Androgen Depletion Therapy for Advanced Prostate Cancer.

Authors:  Hideyuki Akaza
Journal:  Curr Urol Rep       Date:  2016-11       Impact factor: 3.092

Review 8.  Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review.

Authors:  Fabrice Smieliauskas; Chun-Ru Chien; Chan Shen; Daniel M Geynisman; Ya-Chen Tina Shih
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

Review 9.  The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.

Authors:  Ethan J Kilmister; Swee T Tan
Journal:  J Histochem Cytochem       Date:  2021-06-24       Impact factor: 2.479

10.  Risk of discontinuation of Advanced Therapy Medicinal Products clinical trials.

Authors:  Eve Hanna; Cecile Rémuzat; Pascal Auquier; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.